abstract |
The present invention includes TNFα bound to KLH, and the TNFα is strongly inactivated (this means that the product has less than 30% cytolytic activity and / or greater than 15000 under Test A conditions) It relates to an immunogenic product (meaning to exhibit an inactivation factor), emulsions and vaccines comprising it, and a method for preparing said immunogenic product. [Selection figure] None |